(dimethoxy-3,5 benzofuryl-2)-carboxylate de methyle | 104796-36-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: (dimethoxy-3,5 benzofuryl-2)-carboxylate de methyle
• 英文别名: methyl 3,5-dimethoxybenzofuran-2-carboxylate；3,5-Dimethoxy-2-benzofurancarboxylic acid, methyl ester；methyl 3,5-dimethoxy-1-benzofuran-2-carboxylate
• CAS: 104796-36-3
• 化学式: C₁₂H₁₂O₅
• 分子量: 236.224
• InChiKey: WMFWTDVSFKHGRP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  57.9
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (dimethoxy-3,5 benzofuryl-2)-carboxylate de methyle 在 sodium carbonate 作用下， 反应 1.0h， 以80%的产率得到3,5-dimethoxybenzofuran-2-carboxylic acid
  参考文献：
  名称：

  Lamotte; Demerseman; Royer, European Journal of Medicinal Chemistry, 1986, vol. 21, # 5, p. 379 - 383

  摘要：

  DOI：
• 作为产物：
  描述：

  methyl 5-methoxy-2-(2-methoxy-2-oxoethoxy)benzoate 在 sodium methylate 、 potassium carbonate 作用下， 以 甲醇 、 丙酮 为溶剂， 生成 (dimethoxy-3,5 benzofuryl-2)-carboxylate de methyle
  参考文献：
  名称：

  Synthetic Models Related to Methoxalen – CYP2A6 Interactions. Dimethoxybenzofuran Derivatives as Potent and Selective Inhibitors of CYP2A6

  摘要：

  The human CYP2A6 enzyme metabolizes several xenobiotics including nicotine, the addictive component in tobacco. Reduced activity of CYP2A6, either for genetic reasons or by administering inhibitors of CYP2A6, reduces tobacco smoking. The reported compound methoxalen had a potent inhibitory effect on activity of CYP2A6 with an IC50 value of 1.27 mu M. We selected methoxalen as a lead compound and prepared various dimethoxybenzofuran derivatives that have inhibitory effects on activity of human cytochrome P450 (CYP) 2A6. Synthetic benzofuran derivatives (3,6-dimethoxybenzofuran: IC50=1.92 mu M and 3,7-dimethoxybenzofuran: IC50=2.00 mu M) also exhibited comparable activities against CYP2A6 and were selective inhibitors of CYP2A6. These compounds can be used as lead compounds in the development of drugs for smoking reduction therapy.

  DOI：

  10.3987/com-13-12744

文献信息

• Benzothiophenes and benzofurans and antiallergic use thereof
  申请人：Warner-Lambert Company

  公开号：US04703053A1

  公开（公告）日：1987-10-27

  Novel benzothiophene and benzofuran derivatives having antiallergic activity are described as well as a method of manufacture, pharmaceutical compositions, and methods of use therefor. The disclosure describes the use of derivatives for prevention of the release of mediators including histamine and leukotrienes from basophils and mast cells, and prevent respiratory burst in neutrophils providing activity useful in cardiovascular disorders as well as in antiinflammatory, psoriasis, and antimigraine treatment.

  本发明涉及具有抗过敏活性的新型苯并噻吩和苯并呋喃衍生物，以及制备方法、药物组合物和使用方法。本发明描述了使用衍生物预防嗜碱性粒细胞和肥大细胞释放组织胺和白三烯等介质，并防止嗜中性粒细胞呼吸爆发，从而提供在心血管疾病、抗炎、银屑病和抗偏头痛治疗中有用的活性。
• CONNOR, DAVID T.;CETENKO, WIACZESLAW A.;UNANGST, PAUL C.;JOHNSON, ELIZABE+
  作者：CONNOR, DAVID T.、CETENKO, WIACZESLAW A.、UNANGST, PAUL C.、JOHNSON, ELIZABE+

  DOI：——

  日期：——
• LAMOTTE G.; DEMERSEMAN P.; ROYER R.; GAYRAL PH.; FOURNIAT J., EUR. J. MED. CHEM., 21,(1986) N 5, 379-383
  作者：LAMOTTE G.、 DEMERSEMAN P.、 ROYER R.、 GAYRAL PH.、 FOURNIAT J.

  DOI：——

  日期：——
• Lamotte; Demerseman; Royer, European Journal of Medicinal Chemistry, 1986, vol. 21, # 5, p. 379 - 383
  作者：Lamotte、Demerseman、Royer、et al.

  DOI：——

  日期：——
• Synthetic Models Related to Methoxalen – CYP2A6 Interactions. Dimethoxybenzofuran Derivatives as Potent and Selective Inhibitors of CYP2A6
  作者：Kazuaki Oda、Yuki Yamaguchi、Ichie Akimoto、Teruki Yoshimura、Keiji Wada、Naozumi Nishizono、Kyoko Motegi

  DOI：10.3987/com-13-12744

  日期：——

  The human CYP2A6 enzyme metabolizes several xenobiotics including nicotine, the addictive component in tobacco. Reduced activity of CYP2A6, either for genetic reasons or by administering inhibitors of CYP2A6, reduces tobacco smoking. The reported compound methoxalen had a potent inhibitory effect on activity of CYP2A6 with an IC50 value of 1.27 mu M. We selected methoxalen as a lead compound and prepared various dimethoxybenzofuran derivatives that have inhibitory effects on activity of human cytochrome P450 (CYP) 2A6. Synthetic benzofuran derivatives (3,6-dimethoxybenzofuran: IC50=1.92 mu M and 3,7-dimethoxybenzofuran: IC50=2.00 mu M) also exhibited comparable activities against CYP2A6 and were selective inhibitors of CYP2A6. These compounds can be used as lead compounds in the development of drugs for smoking reduction therapy.